Can Alzheimer’s Disease Be Treated With Hyperbaric Oxygen Therapy?

Hyperbaric Oxygen Therapy Reading Time: 2 minutes

In the United States, Alzheimer’s disease is the sixth leading cause of death. More than one in three senior citizens die of Alzheimer’s or other dementia diseases. As more Americans become older, the number of people afflicted with Alzheimer’s disease, also increases. Up until recently, if you or a loved one was diagnosed with Alzheimer’s, sadly, there was no cure. However, in recent years, numerous studies have proven that Hyperbaric Oxygen Therapy (HBOT) could ease some of the symptoms of Alzheimer’s disease.

HBOT uses high pressure oxygen to treat basic pathophysiologic processes and their diseases. Doctors use HBOT to treat ailments such as Parkinsons’, arthritis, autism and more. In fact, there are more than 20 afflictions that HBOT is currently being used to treat.

HBOT is a safe and effective method to treat dozens of conditions. The increased pressure of oxygen provided by HBOT significantly reduces inflammation, increases stem cell growth, and stimulates new blood vessels. Numerous studies, in addition to the ones mentioned earlier, support the benefits of HBOT in healing a variety of brain injuries.

HBOT Studies Prove its Efficacy on Alzheimer’s Disease

2001 was the year that the first Alzheimer’s inflicted patient was successfully treated with HBOT. At the time, the nearly 60-year-old Caucasian patient had been suffering Alzheimer’s decline for five years. The patient’s HBOT consisted of 50 minutes of treatment a day, five days per week. After only 21 treatments, the patient reported a remarkable improvement in daily function, like the ability to do a crossword, draw a clock face, and increased energy levels. Once the entire 40-day treatment had concluded, the patient reported an improvement in memory, sleep, conversation ability, and motor speed.

Dr. Paul Harch reported the first evidence of improvement in an Alzheimer’s inflicted brain with hyperbaric oxygen therapy. “We demonstrated the largest improvement in brain metabolism of any therapy for Alzheimer’s disease,” notes Dr. Harch. “HBOT in this patient may be the first treatment not only to halt, but temporarily reverse disease progression in Alzheimer’s disease.”

Dr. Harch based his findings on video imaging, which clearly illustrates the improvements in the brain. PET imaging is a reliable procedure to illustrate responses to certain therapies. As a result, such images are irrefutable evidence that HBOT does indeed offer recovery from dementia.

A recent study conducted by the University of Tel Aviv in Israel, also concluded HBOT provides systematic relief to Alzheimer’s disease. The study examined mice, genetically engineered to possess Alzheimer’s disease. The mice showed reductions in symptoms after HBOT.

The study subjected a group of transgenic mice and a group of wild animals to an hour of HBOT for 14 days, and observed how the therapy affected the animal’s behavior as well as their brain tissue. After 14 days, the scientists discovered that HBOT reduced brain inflammation by 40%. In addition, behavioral symptoms were markedly improved, posing a glimmer of hope for patients with Alzheimer’s disease.

The results of these recent studies have provided much awaited promise of easing the effects and disease of Alzheimer’s for so many patients and their families. Schedule your consultation today with us at RegenQuest for world class HBOT treatment.